Updated:
Partners Healthcare System
Partners HealthCare launched in 1994 as the parent system for Massachusetts General Hospital and Brigham and Women's Hospital, co-founded to consolidate...
Partners Healthcare System
Partners HealthCare launched in 1994 as the parent system for Massachusetts General Hospital and Brigham and Women's Hospital, co-founded to consolidate bargaining power and integrate clinical care with the research output of Harvard Medical School, its principal teaching affiliate. The system grew to absorb community hospitals like Faulkner, Newton-Wellesley, and North Shore Medical Center. In 2020, it rebranded as Mass General Brigham, signaling a unified consumer-facing identity while retaining the individual hospital brands for clinical care. The board is led by private equity veteran Scott Sperling of Thomas H. Lee Partners, with John Fish of Suffolk Construction and Jonathan Kraft of The Kraft Group serving as vice chairs — an uncommon concentration of Boston commercial real estate and sports-industry operators governing a charitable system. Today Mass General Brigham's investment posture is defined by its dual structure as a healthcare provider and an asset allocator. It directly owns and develops institutional real estate: the Assembly Row headquarters campus in Somerville, the MGH clinical complex in the West End, and the Brigham corridor along Francis Street. Its venture arm, Mass General Brigham Ventures, operates as a direct investor in life sciences spinouts from the Harvard-MGH research pipeline, with a portfolio concentrated on therapeutics, devices, and diagnostics companies founded by its own faculty. The balance sheet also supports consortium relationships, including co-ownership of the critical-care transport nonprofit Boston MedFlight alongside Beth Israel Lahey Health and Boston Medical Center. The system's $18 billion-plus revenue base — driven by patient services and NIH research funding — underpins its capital deployment, making it one of the largest asset owners in New England, though it discloses no single investable-asset figure. The system employs roughly 75,000 people across its acute-care hospitals, specialty institutions like McLean Hospital and Spaulding Rehabilitation, and the Mass General Brigham Health Plan, making it the largest private employer in Massachusetts. Philanthropy flows through the Mass General Brigham Foundation, which channels donated capital to individual hospital priorities and system-wide initiatives, while the system's real estate division manages a portfolio that includes the Braintree Lottery Building and a recently completed expansion at the Faulkner campus. In 2023, MGB announced plans for a major ambulatory care expansion across three Massachusetts suburbs, a multi-hundred-million-dollar facility push that continues its pattern of capital-intensive regional expansion. Structurally, Mass General Brigham operates as a hybrid that no peer has replicated at this scale: a charitable not-for-profit presiding over an operating company, a payer, a research institution receiving over $2 billion annually from the NIH, and a direct private investment platform. This concentration of clinical, academic, and financial assets in one system creates unusual governance challenges — the same board overseeing hospital safety, scientific integrity, and venture fund performance — and makes it a singular institutional player in Boston's life sciences ecosystem.
General information
Firm type
Endowment / Foundation
Year founded
1994
Location
Region
North America
Country
United States
City
Somerville
Corporate office
399 Revolution Drive, Somerville, MA, United States
Additional offices
Massachusetts General Hospital Campus, Boston, MA · Brigham and Women's Hospital, Boston, MA
Principals
Scott M. Sperling
Chairman of the Board
John Fish
Vice Chair of the Board
Jonathan Kraft
Vice Chair of the Board
Sector focus
Frequently asked questions
Who governs investment decisions at Mass General Brigham?
Investment governance is split across distinct entities. The system's balance-sheet assets and real estate holdings are overseen by the board of directors, chaired by Scott Sperling of Thomas H. Lee Partners, with vice chairs from the region's largest construction and sports-holding companies. Mass General Brigham Ventures, the system's direct investment arm in life sciences companies, operates as a separate team that deploys capital into faculty-founded startups. The Mass General Brigham Foundation manages the investment of philanthropic endowments designated for individual hospitals and system priorities.
How does Mass General Brigham source its direct investment opportunities?
Mass General Brigham Ventures sources almost all of its pipeline from the Harvard Medical School-affiliated research community housed within MGH, Brigham and Women's, and affiliated institutes. The formal tech transfer office funnels disclosed inventions and faculty-founded companies into the venture portfolio, giving it proprietary access to one of the largest NIH-funded research enterprises in the United States. External syndication typically involves other healthcare venture firms that co-lead rounds alongside the MGB vehicle.
Is the Mass General Brigham Foundation a separate investment entity from the hospital system?
Yes. The Mass General Brigham Foundation is a legally distinct 501(c)(3) that raises and invests philanthropic capital for the system. Its investment portfolio supports restricted grants to individual campuses, including Massachusetts General Hospital and Brigham and Women's Hospital, as well as system-wide research programs. The foundation's allocation decisions are overseen by its own investment committee, not by the operating board of the health system.
What is Mass General Brigham's relationship with Harvard Medical School?
Mass General Brigham is Harvard Medical School's largest teaching affiliate. The vast majority of HMS-affiliated faculty physicians hold clinical appointments at MGH or Brigham and Women's, and the system's hospitals serve as the principal clinical training sites for Harvard medical students and residents. The partnership is a research and talent pipeline, but the two institutions are legally and financially separate entities.
Does Mass General Brigham directly own the real estate at its hospital campuses?
Yes. The system directly owns trophy Boston real estate including the Massachusetts General Hospital campus in the West End, the Brigham and Women's Hospital tower on Francis Street, and the corporate headquarters at Assembly Row in Somerville. Additional owned assets include the Braintree Lottery Building and the recently expanded Faulkner Hospital campus. The board's vice chair John Fish runs Suffolk Construction, the largest builder in Boston, which constructs many of the system's capital projects.
What is the role of Mass General Brigham Ventures?
Mass General Brigham Ventures is the system's direct investment vehicle for life sciences companies founded by or based on the research of its affiliated faculty. It invests at the seed and Series A stages in therapeutics, medical devices, and diagnostics startups emerging from the Harvard-MGH-Brigham research ecosystem. The venture arm typically co-invests alongside external venture firms that specialize in healthcare, and its portfolio companies benefit from clinical validation access within the system's hospitals.
What happened to the Partners HealthCare brand?
Partners HealthCare rebranded to Mass General Brigham in 2020. The name change was designed to foreground the system's two flagship hospitals — Massachusetts General Hospital and Brigham and Women's Hospital — in response to consumer confusion about what 'Partners' meant. The individual hospital brands, including MGH and Brigham and Women's, continue to operate under their original names with the Mass General Brigham parent brand appearing on system-wide communications.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: